文献速递甲状腺与浅表头颈US

基于超声特征的新型甲状腺影像报告和数据系统(TIRADS)用于滤泡性甲状腺肿瘤:一项多中心研究

New Thyroid Imaging Reporting and Data System (TIRADS) Based on Ultrasonography Features for Follicular Thyroid Neoplasms: A Multicenter Study.
PubMed 文献 · Ultrasound Med Biol · 2025-05-31

本研究纳入4家医院535例滤泡性甲状腺肿瘤(FTN),随机分为测试组370例(FTC 111例、FTA 259例)和验证组165例(FTC 51例、FTA 114例),基于超声特征建立FTN-TIRADS。测试组FTN-TIRADS的AUC为0.855,高于EU-RSS(0.759)、ATA-RSS(0.759)、ACR-TIRADS(0.753)和C-TIRADS(0.677)(均p<0.05);验证组AUC为0.879,与测试组无显著差异(p=0.569)。FTN-TIRADS的不必要细针穿刺(FNA)率为41.4%,显著低于其他四种风险分层系统(67.3%、69.0%、60.1%、63.2%)。

要点

  • FTN-TIRADS纳入5项独立超声危险因素:结节成分、回声、钙化、晕环征、与甲状腺包膜分界不清。
  • 结节按0至5个可疑特征分别归为TR2、TR3、TR4a、TR4b、TR4c和TR5。
  • FTN-TIRADS的AUC为0.855,高于EU-RSS、ATA-RSS、ACR-TIRADS和C-TIRADS(均p<0.05)。

核心结论

  • FTN-TIRADS对FTN的鉴别诊断优于现有风险分层系统,并显著降低不必要FNA率,可作为甲状腺滤泡性肿瘤可靠的术前无创评估工具,减少不必要的FNA和手术。

研究设计与样本

  • 回顾性多中心研究,纳入4家医院535例FTN,随机分为测试组370例(FTC 111例、FTA 259例)和验证组165例(FTC 51例、FTA 114例),基于单因素分析和logistic回归建立FTN-TIRADS,并与EU-RSS、ATA-RSS、ACR-TIRADS、C-TIRADS比较。

关键影像表现/征象

  • 结节成分、回声、钙化、晕环征、与甲状腺包膜分界不清为独立危险因素并纳入FTN-TIRADS。
  • 结节按0至5个可疑特征分别分类为TR2、TR3、TR4a、TR4b、TR4c和TR5。

诊断标准与关键数值

  • FTN-TIRADS测试组AUC为0.855,高于EU-RSS(0.759)、ATA-RSS(0.759)、ACR-TIRADS(0.753)和C-TIRADS(0.677)(均p<0.05)。
  • 验证组FTN-TIRADS的AUC为0.879,与测试组AUC 0.855相比无显著差异(p=0.569)。
  • FTN-TIRADS不必要FNA率为41.4%,低于EU-RSS(67.3%)、ATA-RSS(69.0%)、ACR-TIRADS(60.1%)和C-TIRADS(63.2%)。

临床应用与阅片要点

  • 作者认为FTN-TIRADS可作为甲状腺滤泡性肿瘤可靠的术前无创评估工具,减少不必要的FNA和手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Preoperative diagnosis of follicular thyroid neoplasm (FTN) (including follicular thyroid adenoma [FTA] and follicular thyroid carcinoma [FTC]) is difficult and the current ultrasound risk stratification systems (RSSs) for thyroid nodules are not suitable for FTN. Therefore, this study aimed to establish a new RSS for FTN as a useful preoperative evaluation to reduce missed diagnoses and unnecessary biopsies.

METHODS: We included 535 FTNs from four hospitals in this retrospective study. All nodules were divided randomly into a test group (n = 370; 111 FTCs and 259 FTAs) and a validation group (n = 165; 51 FTCs and 114 FTAs). The ultrasound features of each nodule were analyzed. Thyroid Imaging Reporting and Data System (TIRADS) of FTN (FTN-TIRADS) was established based on the results of univariate analysis and logistic regression of ultrasound features. Each nodule was evaluated and classified by these four RSSs (RSS from European Thyroid Association [EU-RSS], RSS from the American Thyroid Association [ATA-RSS], TIRADS from the American College of Radiology [ACR-TIRADS], TIRADS from China [C-TIRADS]) and FTN-TIRADS, respectively. Receiver operating characteristic curve analysis was performed and the area under the receiver operator characteristic curve (AUC) was used to evaluate the diagnostic value of the RSSs mentioned above. The diagnostic value of FTN-TIRADS in the validation group was verified and compared with the test group and other four RSSs. The unnecessary rates of fine needle aspiration (FNA) were calculated and compared between FTN-RIRADS and the other four RSSs.

RESULTS: The test group and validation group included 370 patients (86 male patients) and 165 patients (48 male patients). The following ultrasound features were independent risk factors and included in FTN-TIRADS: nodule composition, echogenicity, calcifications, halo sign, indistinct boundary with the thyroid capsule. Nodules were classified as TR2, TR3, TR4a, TR4b, TR4c, and TR5 with none to five suspicious features described, respectively. The AUC of FTN-TIRADS was 0.855, statistically higher than EU-RSS, ATA-RSS, ACR-TIRADS and C-TIRADS (0.759, 0.759, 0.753, and 0.677, respectively) (all p < 0.05). The FTN-TIRADS of the validation group had similar diagnostic performance to that of the test group (AUC 0.879 vs. AUC 0.855; p = 0.569). The unnecessary FNA rate of the FTN-TIRADS was 41.4%, which was significantly lower than that of EU-RSS (67.3%), ATA-RSS (69.0%), ACR-TIRADS (60.1%), and C-TIRADS (63.2%).

CONCLUSIONS: FTN-TIRADS achieved better differential diagnosis of FTN than current RSSs and significantly reduced the rate of unnecessary FNA. It can serve as a reliable preoperative noninvasive assessment tool for thyroid follicular tumors, reducing unnecessary FNA and unnecessary surgeries.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Liu BJ, Liu YY, Wan J, et al. New Thyroid Imaging Reporting and Data System (TIRADS) Based on Ultrasonography Features for Follicular Thyroid Neoplasms: A Multicenter Study. Ultrasound Med Biol. 2025. PMID: 40451671. doi:10.1016/j.ultrasmedbio.2025.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。